Issue: August 2014
August 01, 2014
1 min read
Save

Trial Scorecard: OACIS

Issue: August 2014

Researchers compared 5-year survival benefits of ACE inhibitors and angiotensin II receptor blockers for patients with acute MI.

Clinical Scorecard: OACIS